PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Flexicare (Group) Limited has Acquired Medisize B.V.

Flexicare (Group) Limited (“Flexicare”), a leading UK headquartered manufacturer of medical devices, is pleased to announce that it has acquired Medisize B.V. from an affiliate of Phillips-Medisize, LLC (“PhillipsMedisize”). Medisize B.V. is a manufacturer specialising in the supply and distribution of a wide range of respiratory and anaesthesia products for critical care, neonatology, emergency, homecare and radiology (“Airway Management”).
 
The acquisition of Medisize B.V. includes operations in the Netherlands, and subsidiaries in Germany and Italy.
 
This transaction provides Flexicare with an enhanced presence in mainland Europe supported by the Medisize B.V. sales and distribution networks in three European geographies. Acquiring Medisize B.V. supplements the Flexicare global product portfolio providing greater choice and coverage for existing and new customers. The sale of Medisize B.V. by Phillips-Medisize will enable both organisations to focus on their differing areas of expertise, and better serve the needs of their distinct customer groups.
 
The business acquired does not include any of the contract manufacturing and design consultancy businesses of Phillips-Medisize in the Netherlands, Czech Republic or elsewhere.
 
Commenting on the deal, Flexicare Managing Director Hash Poormand said: “This transaction underscores our commitment across Europe to be a leader in airway management and anaesthesia, with the ability to deliver and service the market at scale. “The rapid organic growth that we have enjoyed, as a result of our innovative product portfolio and recent acquisitions, will give us further reach and the combination of the two companies will increase the value Flexicare and Medisize B.V. deliver to its customers and end users. The acquisition is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Flexicare’s wider range of anaesthesia and airway management products, truly exciting times ahead.”
 
Matt Jennings, CEO and President, Phillips-Medisize commented: “We believe this is a very positive transaction for both Flexicare and Phillips-Medisize. The Airway Management business closely aligns with Flexicare’s vision. Flexicare’s strength and presence in this market makes them well-positioned to fully leverage the talent and expertise of the Airway Management team in continuing to provide innovative airway management solutions.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026